Spots Global Cancer Trial Database for Breast Mesh Used in Two-staged Breast Reconstruction
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Breast Mesh Used in Two-staged Breast Reconstruction
Official Title: A Prospective Randomized and Controlled Study of Efficacy and Safety of TiLOOP® Bra Mesh in Patients With Expander-Implant Breast Reconstruction.
Study ID: NCT04967976
Study Description
Brief Summary: This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, improve the efficiency of expansion and provide better aesthetic result.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
MD Anderson Cancer Center, Houston, Texas, United States
Gansu Provincial Cancer Hospital, Lanzhou, Gansu, China
Jilin Cancer Hospital, Ch'ang-ch'un, Jilin, China
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Technical University of Munich, Munich, , Germany
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
